DONNA CLEMENT: Open Payments
NPI 1629272620 · ALAMO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 49 payments from 12 companies in 2025. Trend: 2023 $822 · 2024 $1,103 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $271 |
| ABBVIE INC. | 11 | $167 |
| GlaxoSmithKline, LLC. | 5 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Lilly USA, LLC | 5 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $46 |
| Amgen Inc. | 2 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: Ozempic, REXULTI, TRELEGY ELLIPTA, VRAYLAR, Wegovy, MOUNJARO, QULIPTA, JOURNAVX.
Industry payments across TN — which companies pay providers there.
